Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESCIENT
NCT05556746Phase 2Active, not recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Nov 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bedaquiline, clofazimine, delamanid, pyrazinamide in Tuberculosis (TB), sponsored by Brigham and Women's Hospital. Started Nov 2023; status: active, not recruiting.
02
Drugs
bedaquilineclofaziminedelamanidpyrazinamide
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05556746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05556746.